THE WHAT? Mondi has announced that it has agreed to sell its personal care components business to Nitto Denko Corporation for an enterprise value of €615 million.
THE DETAILS Once the deal is tied up, the remaining portion of Engineered Materials will be merged into the Flexible packaging business unit, Mondi said. The transaction is subject to clearance by the relevant competition authorities and is expected to close in the second half of the year.
“We are pleased to have agreed the sale of PCC to Nitto, knowing they will be great owners of the business,” commented Mondi Group Chief Executive Officer, Andrew King. “By simplifying our portfolio, the transaction will enable us to focus on our core packaging and paper businesses and enhance our ability to pursue our strategic priority to grow in sustainable packaging. We remain excited by our opportunity to further serve our customers with innovative solutions that are sustainable by design.”
THE WHY? Mondi said in a statement that its focus to grow in packaging and the limited overlap of PCC with the rest of its business led it to conclude that the next phase of PCC’s development will be better undertaken outside of the group. The proceeds from the sale will be used for ‘general corporate purposes’.
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
